Invention Grant
US08524906B2 Tetrahydrothiazolopyridine inhibitors of phosphatidylinositol 3-kinase
失效
磷脂酰肌醇3-激酶的四氢噻唑并吡啶抑制剂
- Patent Title: Tetrahydrothiazolopyridine inhibitors of phosphatidylinositol 3-kinase
- Patent Title (中): 磷脂酰肌醇3-激酶的四氢噻唑并吡啶抑制剂
-
Application No.: US13211502Application Date: 2011-08-17
-
Publication No.: US08524906B2Publication Date: 2013-09-03
- Inventor: Alex Aronov , Upul Keerthi Bandarage , Kevin Michael Cottrell , Robert J. Davies , Elaine B. Krueger , Mark Willem Ledeboer , Brian Ledford , Arnaud Le Tiran , David Messersmith , Tiansheng Wang , Jinwang Xu , Yusheng Liao
- Applicant: Alex Aronov , Upul Keerthi Bandarage , Kevin Michael Cottrell , Robert J. Davies , Elaine B. Krueger , Mark Willem Ledeboer , Brian Ledford , Arnaud Le Tiran , David Messersmith , Tiansheng Wang , Jinwang Xu , Yusheng Liao
- Applicant Address: US MA Cambridge
- Assignee: Vertex Pharmaceuticals Incorporated
- Current Assignee: Vertex Pharmaceuticals Incorporated
- Current Assignee Address: US MA Cambridge
- Agent Daniel A. Pearson
- Main IPC: A61K31/4365
- IPC: A61K31/4365 ; C07D513/04
Abstract:
The present invention relates to compounds useful as inhibitors of PI3K, particularly of PI3Kγ. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.
Public/Granted literature
- US20120039849A1 TETRAHYDROTHIAZOLOPYRIDINE INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE Public/Granted day:2012-02-16
Information query
IPC分类:
